Document is current
Any future updates will be listed below
-
Authors
Luo, Qiang
Zhang, Lingli
Huang, Chu-Chung
Zheng, Yan
Kanen, Jonathan W.
Zhao, Qi
Yao, Ye
Quinlan, Erin B.
Jia, Tianye
Banaschewski, Tobias
Bokde, Arun L. W.
Bromberg, Uli
Büchel, Christian
Flor, Herta
Frouin, Vincent
Garavan, Hugh
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Poustka, Luise
Hohmann, Sarah
Fröhner, Juliane H.
Smolka, Michael N.
Walter, Henrik
Whelan, Robert
Sahakian, Barbara J.
Schumann, Gunter
Li, Fei
Feng, Jianfeng
Desrivières, Sylvane
Robbins, Trevor W.
,
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2018YFC0910503)
National Natural Science Foundation of China (81873909)
Natural Science Foundation of Shanghai (17ZR1444400)
Shanghai Municipal Science and Technology Major Project (2018SHZDZX01)
Zhangjiang Lab
National Natural Science Foundation of China (81571031, 81761128035, and 81930095)
Shanghai Municipal Commission of Health and Family Planning (2017ZZ02026, 2018BR33, 2017EKHWYX-02 and GDEK201709)
Shanghai Shenkang Hospital Development (16CR2025B)
Shanghai Municipal Education Commission (20152234)
Shanghai Committee of Science and Technology (17XD1403200, 19410713500, and 18DZ2313505)
Key projects of Guangdong Province (2018B030335001)
Xinhua Hospital of Shanghai Jiao Tong University School of Medicine (Xinhua Hospital of Shanghai Jiao Tong University School of Medicine)
key project of Shanghai Science and Technology Innovation Plan (16JC1420402)
the National Natural Science Foundation of China (91630314)
the Shanghai AI Platform for Diagnosis and Treatment of Brain Diseases
the Project of Zhangjiang Hi-Tech District Management Committee
Shanghai
111 project (B18015)
the European Union-funded FP6 Integrated Project IMAGEN (LSHM-CT-2007-037286)
the Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (695313)
ERANID (PR-ST-0416-10004)
BRIDGET (MR/N027558/1)
Associazione Emma e Ernesto Rulfo per la Genetica Medica
MATRICS (603016)
the Innovative Medicine Initiative Project EU-AIMS (115300-2)
the Medical Research Council Grant 'c-VEDA' (MR/N000390/1)
the Swedish Research Council FORMAS
the Medical Research Council
the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London
the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; eMED SysAlc01ZX1311A; Forschungsnetz AERIAL 01EE1406A, 01EE1406B)
the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940/2)
the Medical Research Foundation and Medical research council (MR/R00465X/1)
the Human Brain Project
ANR (project AF12-NEUR0008-01 - WM2NA, and ANR-12-SAMA-0004)
the Fondation de France, the Fondation pour la Recherche Médicale
the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA)
the Assistance-Publique-Hôpitaux-de-Paris and INSERM
Paris Sud University IDEX 2012
the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797)
U.S.A. (RO1 MH085772-01A1)
NIH Consortium grant (U54 EB020403)
cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence
National Key R&D Program of China (2019YFA0709502)
- License Information
-
More Information
Article History
Received: 26 March 2020
Accepted: 11 August 2020
First Online: 15 October 2020
Ethics approval and consent to participate
: For the IMAGEN study, the local research ethics committees approved this study and written consent was obtained from participants. When the children were under 18 years old (baseline and first follow-up), the children gave assent and their parents or legal guardian provided written informed consent. The UKB study has obtained ethics approval from the Research Ethics Committee (REC #11/NW/0382) and informed consent from all participants enrolled. The WU-Minn HCP Consortium obtained full informed consent from all participants, and research procedures and ethical guidelines were followed in accordance with the Washington University Institutional Review Boards (IRB #201204036).
: Not applicable.
: Dr. Banaschewski has served as an advisor or consultant to Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Neurim Pharmaceuticals, Novartis, and Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire and Vifor Pharma; the present work is unrelated to these relationships. Dr. Walter received a speaker honorarium from Servier (2014). Dr. Sahakian consults for Cambridge Cognition and Peak, UK. Dr. Robbins reports consultancy with Cambridge Cognition, Unilever, Mundipharma, Greenfield Bioventures Inc., research grants from Shionogi, Lundbeck, Small Pharma, royalties for CANTAB from Cambridge Cognition, and editorial honoraria from Elsevier, Springer Verlag, outside the submitted work. The other authors report no biomedical financial interests or potential conflicts of interest.
